Slusher Tina M, Zamora Tara G, Appiah Duke, Stanke Judith U, Strand Mark A, Lee Burton W, Richardson Shane B, Keating Elizabeth M, Siddappa Ashajoythi M, Olusanya Bolajoko O
Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
Hennepin County Medical Center, Minneapolis, Minnesota, USA.
BMJ Paediatr Open. 2017 Nov 25;1(1):e000105. doi: 10.1136/bmjpo-2017-000105. eCollection 2017.
To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which may result in death or irreversible brain damage with disabilities in survivors. Population-based data establishing the global burden of SNJ has not been previously reported.
Determine the burden of SNJ in all WHO regions, as defined by clinical jaundice associated with clinical outcomes including acute bilirubin encephalopathy/kernicterus and/or exchange transfusion (ET) and/or jaundice-related death.
PubMed, Scopus and other health databases were searched, without language restrictions, from 1990 to 2017 for studies reporting the incidence of SNJ.
STUDY SELECTION/DATA EXTRACTION: Stratification was performed for WHO regions and results were pooled using random effects model and meta-regression.
Of 416 articles including at least one marker of SNJ, only 21 reported estimates from population-based studies, with 76% (16/21) of them conducted in high-income countries. The African region has the highest incidence of SNJ per 10 000 live births at 667.8 (95% CI 603.4 to 738.5), followed by Southeast Asian, Eastern Mediterranean, Western Pacific, Americas and European regions at 251.3 (132.0 to 473.2), 165.7 (114.6 to 238.9), 9.4 (0.1 to 755.9), 4.4 (1.8 to 10.5) and 3.7 (1.7 to 8.0), respectively. The incidence of ET per 10 000 live births was significantly higher for Africa and Southeast Asian regions at 186.5 (153.2 to 226.8) and 107.1 (102.0 to 112.5) and lower in Eastern Mediterranean (17.8 (5.7 to 54.9)), Americas (0.38 (0.21 to 0.67)), European (0.35 (0.20 to 0.60)) and Western Pacific regions (0.19 (0.12 to 0.31). Only 2 studies provided estimates of clear jaundice-related deaths in infants with significant jaundice [UK (2.8%) and India (30.8%).
Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries.
为评估全球范围内严重新生儿黄疸(SNJ)管理延迟和/或不佳的负担,这是一个全球性常见问题,可能导致死亡或幸存者出现不可逆的脑损伤并伴有残疾。此前尚未有基于人群的数据来确定SNJ的全球负担。
确定世界卫生组织(WHO)所有区域中SNJ的负担,其定义为与包括急性胆红素脑病/核黄疸和/或换血治疗(ET)和/或黄疸相关死亡等临床结局相关的临床黄疸。
检索了1990年至2017年的PubMed、Scopus和其他健康数据库,检索无语言限制,以查找报告SNJ发病率的研究。
研究选择/数据提取:对WHO各区域进行分层,并使用随机效应模型和元回归对结果进行汇总。
在416篇至少包含一项SNJ指标的文章中,只有21篇报告了基于人群研究的估计值,其中76%(16/21)是在高收入国家进行的。非洲区域每10000例活产中SNJ的发病率最高,为667.8(95%置信区间603.4至738.5),其次是东南亚、东地中海、西太平洋、美洲和欧洲区域,分别为251.3(132.0至473.2)、165.7(114.6至238.9)、9.4(0.1至755.9)、4.4(1.8至10.5)和3.7(1.7至8.0)。非洲和东南亚区域每10000例活产中ET的发病率显著更高,分别为186.5(153.2至226.8)和107.1(102.0至112.5),而东地中海(17.8(5.7至54.9))、美洲(0.38(0.21至0.67))、欧洲(0.35(0.20至0.60))和西太平洋区域(0.19(0.12至0.31))较低。只有2项研究提供了患有显著黄疸的婴儿中明确的黄疸相关死亡估计值[英国(2.8%)和印度(30.8%)]。
有限但令人信服的证据表明,SNJ与重大的健康负担相关,尤其是在低收入和中等收入国家。